Cargando…
N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide
In the title compound, C(24)H(28)N(2)O(3)S, the pendant methyl C atom bonded to the cyclohexane ring is disordered over two sites in a 0.580 (11):0.420 (11) ratio. The cyclohexane ring adopts a distorted chair conformation while the thiazolidine ring has an envelope conformation. The two phenyl r...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959300/ https://www.ncbi.nlm.nih.gov/pubmed/21201127 http://dx.doi.org/10.1107/S1600536808028651 |
_version_ | 1782188466419793920 |
---|---|
author | Yalçın, Şerife Pınar Akkurt, Mehmet Şahin, Ertan Güzel, Özlen Salman, Aydın İhan, Eser |
author_facet | Yalçın, Şerife Pınar Akkurt, Mehmet Şahin, Ertan Güzel, Özlen Salman, Aydın İhan, Eser |
author_sort | Yalçın, Şerife Pınar |
collection | PubMed |
description | In the title compound, C(24)H(28)N(2)O(3)S, the pendant methyl C atom bonded to the cyclohexane ring is disordered over two sites in a 0.580 (11):0.420 (11) ratio. The cyclohexane ring adopts a distorted chair conformation while the thiazolidine ring has an envelope conformation. The two phenyl rings make a dihedral angle of 71.8 (2)° with each other. The conformation is stabilized by an intramolecular N—H⋯O hydrogen bond. In the crystal structure, an intermolecular hydrogen bond O—H⋯O occurs. |
format | Text |
id | pubmed-2959300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-29593002010-12-30 N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide Yalçın, Şerife Pınar Akkurt, Mehmet Şahin, Ertan Güzel, Özlen Salman, Aydın İhan, Eser Acta Crystallogr Sect E Struct Rep Online Organic Papers In the title compound, C(24)H(28)N(2)O(3)S, the pendant methyl C atom bonded to the cyclohexane ring is disordered over two sites in a 0.580 (11):0.420 (11) ratio. The cyclohexane ring adopts a distorted chair conformation while the thiazolidine ring has an envelope conformation. The two phenyl rings make a dihedral angle of 71.8 (2)° with each other. The conformation is stabilized by an intramolecular N—H⋯O hydrogen bond. In the crystal structure, an intermolecular hydrogen bond O—H⋯O occurs. International Union of Crystallography 2008-09-13 /pmc/articles/PMC2959300/ /pubmed/21201127 http://dx.doi.org/10.1107/S1600536808028651 Text en © Yalçın et al. 2008 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Organic Papers Yalçın, Şerife Pınar Akkurt, Mehmet Şahin, Ertan Güzel, Özlen Salman, Aydın İhan, Eser N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide |
title |
N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide |
title_full |
N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide |
title_fullStr |
N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide |
title_full_unstemmed |
N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide |
title_short |
N-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide |
title_sort | n-(2,6-dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2-diphenylacetamide |
topic | Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959300/ https://www.ncbi.nlm.nih.gov/pubmed/21201127 http://dx.doi.org/10.1107/S1600536808028651 |
work_keys_str_mv | AT yalcınserifepınar n26dimethyl3oxo1thia4azaspiro45dec4yl2hydroxy22diphenylacetamide AT akkurtmehmet n26dimethyl3oxo1thia4azaspiro45dec4yl2hydroxy22diphenylacetamide AT sahinertan n26dimethyl3oxo1thia4azaspiro45dec4yl2hydroxy22diphenylacetamide AT guzelozlen n26dimethyl3oxo1thia4azaspiro45dec4yl2hydroxy22diphenylacetamide AT salmanaydın n26dimethyl3oxo1thia4azaspiro45dec4yl2hydroxy22diphenylacetamide AT ihaneser n26dimethyl3oxo1thia4azaspiro45dec4yl2hydroxy22diphenylacetamide |